Zur Kurzanzeige

EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment

dc.contributor.authorZhang, Chaoyu
dc.contributor.authorSheng, Wenjie
dc.contributor.authorAl-Rawe, Marwah
dc.contributor.authorMohiuddin, T. M.
dc.contributor.authorNiebert, Marcus
dc.contributor.authorZeppernick, Felix
dc.contributor.authorMeihold-Heerlein, Ivo
dc.contributor.authorHussain, Ahmad Fawzi
dc.date.accessioned2022-08-19T05:16:58Z
dc.date.available2022-08-19T05:16:58Z
dc.date.issued2022
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/6562
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-6013
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:610
dc.titleEpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.spage1
local.source.epage13
local.source.journaltitleInternational journal of molecular sciences
local.source.volume23
local.source.articlenumber6122
local.source.urihttps://doi.org/10.3390/ijms23116122


Dateien zu dieser Ressource

Thumbnail
Name:
10.3390_ijms23116122.pdf
Größe:
4.375Mb
Format:
PDF
Öffnen

Das Dokument erscheint in:

Zur Kurzanzeige

Namensnennung 4.0 International